Mirati Therapeutics, Inc.

BAKER BROS. ADVISORS LP

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

4,121,440

Value ($000)

242,135

Weight

2.8%

2013 Q4 - 2023 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	242,135	2.8%	4,121,440	12/31/2023
2023 Q3	11/14/2023	61,410	0.4%	1,409,784	9/30/2023
2023 Q2	8/14/2023	50,935	0.3%	1,409,784	6/30/2023
2023 Q1	5/15/2023	52,416	0.3%	1,409,784	3/31/2023
2022 Q4	2/14/2023	63,877	0.4%	1,409,784	12/31/2022
2022 Q3	11/14/2022	98,459	0.6%	1,409,784	9/30/2022
2022 Q2	8/15/2022	94,639	0.5%	1,409,784	6/30/2022
2022 Q1	5/16/2022	115,912	0.7%	1,409,784	3/31/2022
2021 Q4	2/14/2022	206,801	1.0%	1,409,784	12/31/2021
2021 Q3	11/15/2021	249,405	1.1%	1,409,784	9/30/2021
2021 Q2	8/16/2021	227,722	1.0%	1,409,784	6/30/2021
2021 Q1	5/17/2021	241,496	1.0%	1,409,784	3/31/2021
2020 Q4	2/16/2021	309,645	1.2%	1,409,784	12/31/2020
2020 Q3	11/16/2020	234,095	0.9%	1,409,784	9/30/2020
2020 Q2	8/14/2020	160,955	0.7%	1,409,784	6/30/2020
2020 Q1	5/15/2020	108,370	0.7%	1,409,784	3/31/2020
2019 Q4	2/14/2020	168,448	0.9%	1,307,220	12/31/2019
2014 Q1	5/15/2014	45,388	0.6%	2,380,074	3/31/2014
2013 Q4	2/14/2014	39,581	0.6%	2,380,074	12/31/2013